B&B Tools AB

ÜBERBLICK |  NEWS |  MULTIMEDIA  | FORSCHUNG

---

B&B Tools AB Company Summary

Mit einem Umsatz von rund 2,8 Milliarden Euro im Jahr 2007 und einem Marktanteil von elf Prozent ist Novartis die umsatzstärkste Pharmaunternehmensgruppe im deutschen Gesundheitsmarkt.

COMPANY DATA

	Principal Sector	Gesundheit & Pharm
	Principal Industry	Pharmaceutical
	Homepage	www.novartis.de

---

Key Developments: B&B Tools AB

	Novartis International AG (VTX:NOVN) Novartis Launches Extavia®, A New Therapeutic Option To Help Patients Combat Devastating Symptoms Of Multiple Sclerosis JAN 22, 2009 17:17 - Article Views: 1,348 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) Four Innovative Novartis Medicines For Cancer, Asthma, High Blood Pressure And Wet AMD Approved In Japan JAN 21, 2009 17:17 - Article Views: 833 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) US Department Of Health And Human Services Awards Novartis USD 486 million Contract To Build Manufacturing Facility For Pandemic Flu Vaccine JAN 16, 2009 02:03 - Article Views: 1,075 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) New Study First To Confirm Sandostatin® LAR® Controls Tumor Growth In Patients With Rare Gastrointestinal Tumors JAN 14, 2009 10:03 - Article Views: 1,588 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) Afinitor® Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More Prior Treatments JAN 14, 2009 10:01 - Article Views: 695 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) Novartis Strengthens Vaccine Pipeline With Agreement For Novel CMV vaccines Candidate DEC 29, 2008 17:17 - Article Views: 577 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) Glivec Receives US Approval As First Treatment To Reduce Risk Of Cancer Returning In Patients With Gastrointestinal Stromal Tumors DEC 20, 2008 12:17 - Article Views: 6,385 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) Afinitor® Shows Potential To Reverse Resistance To Herceptin®[*] In Metastatic Breast Cancer Patients, Leading To Phase III Trial DEC 13, 2008 10:03 - Article Views: 677 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) First Phase III Results For FTY720, A Novel Oral Therapy For MS, Show Superior Efficacy Compared To Interferon Beta-1a DEC 12, 2008 17:17 - Article Views: 803 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (VTX:NOVN) New Data Show Zometa® Enhances Impact Of Chemotherapy On Reducing Breast Tumor Size DEC 12, 2008 07:03 - Article Views: 522 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

5,066 COMPANY PROFILE VIEWS

Diese Seite wurde besucht: (letzten 7 Tagen: 4) (letzten 30 Tagen: 25) (seit Veröffentlichung: 1016)